HEMATOLOGY Imatinib-should we have more of a good thing?

被引：0
|
作者：
Apperley, Jane F. [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, London W12 0NN, England
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2010年 / 7卷 / 06期
关键词：
CHRONIC MYELOID-LEUKEMIA; 800; MG; EXPRESSION; RISK;
D O I：
10.1038/nrclinonc.2010.68
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Imatinib 400 mg has been the first-line therapy for chronic myeloid leukemia (CML) since 2001 but may have been licensed at too low a dose. A recent study compared the standard dose with higher doses in patients with newly diagnosed CML and found no difference in response rates at 12 months. But, is the devil in the detail?
引用
收藏
页码：303 / 304
页数：2
相关论文
共 50 条
  • [41] Should we worry when we have a SMILE?
    Marcus, D.
    Marcus, N.
    Jedrzejak, P.
    Shaikh, H.
    Marcus, S.
    Davies, A.
    Li, H.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 : 17 - 18
  • [42] We Should Have Seen It Coming
    Mathews, Jessica T.
    FOREIGN AFFAIRS, 2020, 99 (06) : 175 - 176
  • [43] Should we have lay justices?
    Vermeule, Adrian
    STANFORD LAW REVIEW, 2007, 59 (06) : 1569 - 1611
  • [44] SHOULD WE HAVE A CAPITAL BUDGET
    MUSGRAVE, RA
    REVIEW OF ECONOMICS AND STATISTICS, 1963, 45 (02) : 134 - 137
  • [45] The lunch that we should have had
    Miles, John
    WALLACE STEVENS JOURNAL, 2011, 35 (02) : 279 - 279
  • [46] WE SHOULD HAVE KNOWN BETTER
    WEEKS, B
    MATERIALS ENGINEERING, 1972, 75 (05): : 6 - &
  • [47] We have the technology, but should we build the test?
    Van Der Pol, Barbara
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (11) : 917 - 919
  • [48] We should have done it before
    Boukantar, M.
    Gellen, B.
    Champagne, S.
    Teiger, E.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1216 - 1216
  • [49] Should We Have Selfish Microgrids?
    Feleafel, Hanaa
    Radulovic, Jovana
    Leseure, Michel
    ENERGIES, 2024, 17 (16)
  • [50] ''We should have seen it coming''
    Sosnoff, M
    FORBES, 1996, 157 (04): : 144 - 144
12345